Considerations for statin therapy in patients with COVID-19.
Identifieur interne : 000248 ( Main/Exploration ); précédent : 000247; suivant : 000249Considerations for statin therapy in patients with COVID-19.
Auteurs : Simin Dashti-Khavidaki [Iran] ; Hossein Khalili [Iran]Source :
- Pharmacotherapy [ 1875-9114 ] ; 2020.
Abstract
Current coronavirus pandemic named coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 is the third coronavirus outbreak during the current century after severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses.1 Acute respiratory distress syndrome (ARDS) is an immunopathologic event and main cause of death following COVID-19. The main mechanism of ARDS is uncontrolled systemic inflammatory response and cytokine storm following release of proinflammatory cytokines (such as interferons (IFN), interleukines (IL), tumor necrosis factor (TNF)-α) and chemokines.2-3 So, some Chinese researchers proposed or used anti-inflammatory agents in the treatment regimen of patients with COVID-19.3-4.
DOI: 10.1002/phar.2397
PubMed: 32267560
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000066
- to stream PubMed, to step Curation: 000066
- to stream PubMed, to step Checkpoint: 000256
- to stream Ncbi, to step Merge: 002725
- to stream Ncbi, to step Curation: 002725
- to stream Ncbi, to step Checkpoint: 002725
- to stream Main, to step Merge: 000251
- to stream Main, to step Curation: 000248
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Considerations for statin therapy in patients with COVID-19.</title><author><name sortKey="Dashti Khavidaki, Simin" sort="Dashti Khavidaki, Simin" uniqKey="Dashti Khavidaki S" first="Simin" last="Dashti-Khavidaki">Simin Dashti-Khavidaki</name><affiliation wicri:level="1"><nlm:affiliation>Professor of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Professor of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation></author><author><name sortKey="Khalili, Hossein" sort="Khalili, Hossein" uniqKey="Khalili H" first="Hossein" last="Khalili">Hossein Khalili</name><affiliation wicri:level="1"><nlm:affiliation>Professor of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Professor of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32267560</idno><idno type="pmid">32267560</idno><idno type="doi">10.1002/phar.2397</idno><idno type="wicri:Area/PubMed/Corpus">000066</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000066</idno><idno type="wicri:Area/PubMed/Curation">000066</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000066</idno><idno type="wicri:Area/PubMed/Checkpoint">000256</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000256</idno><idno type="wicri:Area/Ncbi/Merge">002725</idno><idno type="wicri:Area/Ncbi/Curation">002725</idno><idno type="wicri:Area/Ncbi/Checkpoint">002725</idno><idno type="wicri:Area/Main/Merge">000251</idno><idno type="wicri:Area/Main/Curation">000248</idno><idno type="wicri:Area/Main/Exploration">000248</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Considerations for statin therapy in patients with COVID-19.</title><author><name sortKey="Dashti Khavidaki, Simin" sort="Dashti Khavidaki, Simin" uniqKey="Dashti Khavidaki S" first="Simin" last="Dashti-Khavidaki">Simin Dashti-Khavidaki</name><affiliation wicri:level="1"><nlm:affiliation>Professor of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Professor of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation></author><author><name sortKey="Khalili, Hossein" sort="Khalili, Hossein" uniqKey="Khalili H" first="Hossein" last="Khalili">Hossein Khalili</name><affiliation wicri:level="1"><nlm:affiliation>Professor of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</nlm:affiliation><country xml:lang="fr">Iran</country><wicri:regionArea>Professor of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran</wicri:regionArea><wicri:noRegion>Tehran</wicri:noRegion></affiliation></author></analytic><series><title level="j">Pharmacotherapy</title><idno type="eISSN">1875-9114</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Current coronavirus pandemic named coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 is the third coronavirus outbreak during the current century after severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses.<sup>1</sup> Acute respiratory distress syndrome (ARDS) is an immunopathologic event and main cause of death following COVID-19. The main mechanism of ARDS is uncontrolled systemic inflammatory response and cytokine storm following release of proinflammatory cytokines (such as interferons (IFN), interleukines (IL), tumor necrosis factor (TNF)-α) and chemokines.<sup>2-3</sup> So, some Chinese researchers proposed or used anti-inflammatory agents in the treatment regimen of patients with COVID-19.<sup>3-4</sup>.</div></front></TEI><affiliations><list><country><li>Iran</li></country></list><tree><country name="Iran"><noRegion><name sortKey="Dashti Khavidaki, Simin" sort="Dashti Khavidaki, Simin" uniqKey="Dashti Khavidaki S" first="Simin" last="Dashti-Khavidaki">Simin Dashti-Khavidaki</name></noRegion><name sortKey="Khalili, Hossein" sort="Khalili, Hossein" uniqKey="Khalili H" first="Hossein" last="Khalili">Hossein Khalili</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000248 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000248 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32267560
|texte= Considerations for statin therapy in patients with COVID-19.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32267560" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a MersV1
| This area was generated with Dilib version V0.6.33. |  |